These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 26837582)

  • 1. 2015 FDA drug approvals.
    Mullard A
    Nat Rev Drug Discov; 2016 Feb; 15(2):73-6. PubMed ID: 26837582
    [No Abstract]   [Full Text] [Related]  

  • 2. FDA reveals new initiatives to deal with drug shortages.
    McCarthy M
    BMJ; 2013 Nov; 347():f6646. PubMed ID: 24188905
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA under pressure to relax drug rules.
    Ledford H
    Nature; 2012 Dec; 492(7427):19. PubMed ID: 23222585
    [No Abstract]   [Full Text] [Related]  

  • 4. FDA: friend or foe?
    Lewis TS
    Med Device Technol; 1996 Nov; 7(9):24-30. PubMed ID: 10163675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenomic data: FDA voluntary and required submission guidance.
    Salerno RA; Lesko LJ
    Pharmacogenomics; 2004 Jul; 5(5):503-5. PubMed ID: 15212586
    [No Abstract]   [Full Text] [Related]  

  • 6. Regulatory watch: FDA new drug approvals in Q2 2018.
    Urquhart L
    Nat Rev Drug Discov; 2018 Jul; 17(8):536-537. PubMed ID: 30057412
    [No Abstract]   [Full Text] [Related]  

  • 7. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 8. Today's FDA.
    Slater EE
    N Engl J Med; 2005 Jan; 352(3):293-7. PubMed ID: 15659733
    [No Abstract]   [Full Text] [Related]  

  • 9. Controversy still swirls around FDA user fees: since 1992, the prescription drug user fee act and reauthorizations have sped up new drug approvals--but does speed equal safety?
    Ullman K
    Ann Neurol; 2013 Nov; 74(5):A10-1. PubMed ID: 24353218
    [No Abstract]   [Full Text] [Related]  

  • 10. FDA not NIH can speed new drugs.
    Miller HI
    Nature; 2011 Apr; 472(7342):169. PubMed ID: 21490657
    [No Abstract]   [Full Text] [Related]  

  • 11. Pharmacogenomic data submissions to the FDA: clinical case studies.
    Trepicchio WL; Williams GA; Essayan D; Hall ST; Harty LC; Shaw PM; Spear BB; Wang SJ; Watson ML
    Pharmacogenomics; 2004 Jul; 5(5):519-24. PubMed ID: 15212589
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacogenomic data submissions to the FDA: non-clinical case studies.
    Leighton JK; DeGeorge J; Jacobson-Kram D; MacGregor J; Mendrick D; Worobec A
    Pharmacogenomics; 2004 Jul; 5(5):507-11. PubMed ID: 15212587
    [No Abstract]   [Full Text] [Related]  

  • 13. The approval of Aduhelm risks eroding public trust in Alzheimer research and the FDA.
    Karlawish J; Grill JD
    Nat Rev Neurol; 2021 Sep; 17(9):523-524. PubMed ID: 34267383
    [No Abstract]   [Full Text] [Related]  

  • 14. Moment of reckoning.
    Wadman M
    Nature; 2007 Apr; 446(7138):844-5. PubMed ID: 17443154
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacogenomic data submissions to the FDA: clinical pharmacology case studies.
    Ruaño G; Collins JM; Dorner AJ; Wang SJ; Guerciolini R; Huang SM
    Pharmacogenomics; 2004 Jul; 5(5):513-7. PubMed ID: 15212588
    [No Abstract]   [Full Text] [Related]  

  • 16. 21st century cure, 19th century risk.
    Drug Ther Bull; 2016 Oct; 54(10):109. PubMed ID: 27737906
    [No Abstract]   [Full Text] [Related]  

  • 17. Examining Manufacturing Readiness for Breakthrough Drug Development.
    Dye E; Sturgess A; Maheshwari G; May K; Ruegger C; Ramesh U; Tan H; Cockerill K; Groskoph J; Lacana E; Lee S; Miksinski SP
    AAPS PharmSciTech; 2016 Jun; 17(3):529-38. PubMed ID: 26608693
    [No Abstract]   [Full Text] [Related]  

  • 18. The 21st Century Cures Act: can the regulatory framework survive the "cures"?
    Osorio-de-Castro CG; Caetano R; Pepe VL
    Cad Saude Publica; 2015 Sep; 31(9):1807-10. PubMed ID: 26578005
    [No Abstract]   [Full Text] [Related]  

  • 19. Perspective: protect the USA from UVA.
    Werner MJ
    Nature; 2014 Nov; 515(7527):S126. PubMed ID: 25407712
    [No Abstract]   [Full Text] [Related]  

  • 20. "Fast tracking" drug approvals: is consumer safety being compromised?
    Jacobsen K
    QRC Advis; 2000 Jun; 16(8):5-9. PubMed ID: 10977137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 18.